Vigil Neuroscience
Price & Volume
Stats
See moreOpen | $1.78 |
Previous Close | $1.68 |
Day Range | $1.73-$1.85 |
52W Range | $1.31-$6.06 |
Market Cap | $79.8M |
Shares Short | 423,460 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.07 |
News
See moreYahoo Finance • 20 days ago
Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations at AD/PD™ 2025 International Conference
Yahoo Finance • last month
Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates
Yahoo Finance • 3 months ago
Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical Trial Evaluating VG-3927 for the Potential Treatment of Alzheimer’s Disease
Yahoo Finance • last year
Vigil Neuroscience to Present at Evercore ISI 6th Annual HealthCONx Conference
About
CEO | Dr. Ivana Magovcevic-Liebisch J.D., Ph.D. |
Address | 100 Forge Road, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 69 |
